Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Dual ACE/NEP inhibitors from Fujisawa

Nov. 15, 1996

HLE inhibitors reported by Japan Tobacco

Nov. 15, 1996

Daiichi discloses cerebroprotective agents

Nov. 15, 1996

Senju reports new compounds for treating allergic disorders

Nov. 15, 1996

Safer, more potent antipsychotic agents reported by HMR

Nov. 15, 1996

New antidepressants with improved safety reported by BMS

Nov. 15, 1996

Dutch researcher reports potential CNS agents

Nov. 15, 1996

Antipsychotic agents from Taisho

Nov. 15, 1996

Green Cross describes inhibitors of lipid oxidation

Nov. 15, 1996

New hypolipidemic agents described by Nippon Zoki

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.